Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie Gray told Reuters the company was open to, but not waiting for, a partner to market the drug. More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo Dynavax Technologies Corp said on Monday the U.S. Food and Drug Administration had rejected the marketing applicatio... More »
We use cookies!
By using this site you agree to the use of cookies, more info.